7AY1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Actinium Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.981 EUR 1.45% Market Closed

Market Cap: €29.2m

	Actinium Pharmaceuticals Inc F:7AY1	US
T	Thomson Reuters Corp XMUN:TOC	CA

Profitability Summary

Actinium Pharmaceuticals Inc's profitability score is 32/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-40 274%

Negative 3Y Average Operating Margin

-61 149%

Operating Margin is Increasing

-45 027% > -40 274%

Negative Net Margin

-37 652%

Negative 3Y Average Net Margin

-57 117%

Net Margin is Increasing

-43 250% > -37 652%

Negative Free Cash Flow Margin

-27 427%

Negative 3Y Average Free Cash Flow Margin

-48 880%

Declining Free Cash Flow Margin

-1 208% > -27 427%

Negative ROE

-167%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2 157%

Declining ROIC

3 151% > 1 029%

View All

Hide

Collapse

32 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.